This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
High Point Pharmaceuticals, LLC
Drug Names(s): TTP-854
Description: HPP854 a small molecule beta-secretase-1 (BACE-1) inhibitor.
Deal Structure: HPP854 was identified as a potent and selective inhibitor of BACE using TransTech Pharmas Translational Technology. In 2008, TransTech spun off certain assets to a newly formed company, High Point Pharmaceuticals.
Pink Sheet Beyond Bapi: Alzheimer’s Pipeline Runs Deep
Additional information available to subscribers only: